Clinical Trial: Post Market Clinical Follow-up Study of IrisFITTM PFO (Patent Foramen Ovale) Occluder

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: Post Market Clinical Follow-up Study of IrisFITTM PFO (Patent Foramen Ovale)

Brief Summary:

The purpose of the study is to collect more data about performance and safety of the device called "IrisFITTM PFO occluder". This data will be used to help more patients who will accept treatment with this device in the future.

Patients will undergo routine examination, procedure and follow-up. Related data will be collected and kept in a way that patient info is well protected.


Detailed Summary: This is a Post Market Clinical Follow-up study. Informed consent will be obtained from the patient or from a legally authorized representative of the patient at screening. The patients will be screened (pre-procedure) to determine eligibility for the study. At screening, patients will be assessed for study eligibility by the inclusion/exclusion criteria through their medical history, demographics and transthoracic echocardiography (TTE). Participating patients will have their PFO closed using the IrisFITTM PFO Occluder device. The patients will undergo a clinical examination, electrocardiogram (ECG), clinical laboratory assessment and transthoracic echocardiography (TTE). All periprocedural procedures will be performed according to site´s standard of care.. The efficacy and safety of the devices will be assessed by ECGs, vital signs, physical examination and TTE, which will be done at 1day, at 1month and at 6 months post procedure. Safety will also be assessed at 12 months by telephone visit.
Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.

Current Primary Outcome:

  • Adverse device effects during the procedure up to the point of implanting the study device in the PFO, and during completion of the procedure [ Time Frame: during completion of the procedure ]
    Adverse device effects during the procedure up to the point of implanting the study device in the PFO, and during completion of the procedure
  • Device related adverse event up to 1 month follow-up [ Time Frame: 1 month post procedure ]
    Device related adverse event up to 1 month follow-up
  • Device related adverse event up to 12 month follow-up [ Time Frame: 12 month post procedure ]
    Device related adverse event up to 12 month follow-up
  • Rate of accurate device placement [ Time Frame: 6 month post procedure ]
    Rate of accurate device placement
  • Incidence of device migration/malfunction [ Time Frame: 6 month post procedure ]
    Incidence of device migration/malfunction
  • Successful closure/procedure rate: Proper position of the occluder by imaging, with trivial to small or without residual shunt, 6 month after procedure). [ Time Frame: 6 month post procedure ]
    Successful closure/procedure rate: Proper position of the occluder by imaging, with trivial to small or without residual shunt, 6 month after procedure).


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Lifetech Scientific (Shenzhen) Co., Ltd.

Dates:
Date Received: August 3, 2016
Date Started: September 2014
Date Completion: December 2016
Last Updated: September 1, 2016
Last Verified: August 2016